- In study, test proved able to detect and localize more than 20 types of cancer with a high degree of accuracy
- Test detected methylation patterns associated with cancer in free-floating DNA in blood
A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of the test shows. Dana-Farber Cancer Institute investigators will present the results of the multi-center trial during a session today at the European Society for Medical Oncology (ESMO) 2019 Congress.
The test, developed by GRAIL, Inc., uses next-generation sequencing technology to probe DNA for tiny chemical tags (methylation) that influence whether genes are active or inactive. When applied to nearly 3,600 blood samples – some from patients with cancer, some from people who had not been diagnosed with cancer at the time of the blood draw – the test successfully picked up a cancer signal from the cancer patient samples, and correctly identified the tissue from where the cancer began (the tissue of origin). The test’s specificity – its ability to return a positive result only when cancer is actually present – was high, as was its ability to pinpoint the organ or tissue of origin, researchers found.
The new test looks for DNA, which cancer cells shed into the bloodstream when they die. In contrast to “liquid biopsies,” which detect genetic mutations or other cancer-related alterations in DNA, the technology focuses on modifications to DNA known as methyl groups. Methyl groups are chemical units that can be attached to DNA, in a process called methylation, to control which genes are “on” and which are “off.” Abnormal patterns of methylation turn out to be, in many cases, more indicative of cancer – and cancer type – than mutations are. The new test zeroes in on portions of the genome where abnormal methylation patterns are found in cancer cells.
“Our previous work indicated that methylation-based assays outperform traditional DNA-sequencing approaches to detecting multiple forms of cancer in blood samples,” said the study’s lead author, Geoffrey Oxnard, MD, of Dana-Farber. “The results of the new study demonstrate that such assays are a feasible way of screening people for cancer.”
In the study, investigators analyzed cell-free DNA (DNA that had once been confined to cells but had entered the bloodstream upon the cells’ death) in 3,583 blood samples, including 1,530 from patients diagnosed with cancer and 2,053 from people without cancer. The patient samples comprised more than 20 types of cancer, including hormone receptor-negative breast, colorectal, esophageal, gallbladder, gastric, head and neck, lung, lymphoid leukemia, multiple myeloma, ovarian, and pancreatic cancer.
The overall specificity was 99.4%, meaning only 0.6% of the results incorrectly indicated that cancer was present. The sensitivity of the assay for detecting a pre-specified high mortality cancers (the percent of blood samples from these patients that tested positive for cancer) was 76%. Within this group, the sensitivity was 32% for patients with stage I cancer; 76% for those with stage II; 85% for stage III; and 93% for stage IV. Sensitivity across all cancer types was 55%, with similar increases in detection by stage. For the 97% of samples that returned a tissue of origin result, the test correctly identified the organ or tissue of origin in 89% of cases.
Detecting even a modest percent of common cancers early could translate into many patients who may be able to receive more effective treatment if the test were in wide use, Oxnard remarked.
Learn more: New blood test capable of detecting multiple types of cancer
The Latest on: Blood test for cancer
[google_news title=”” keyword=”blood test for cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Blood test for cancer
- Former state representative Basye stresses importance of yearly screenings after cancer diagnosison April 26, 2024 at 4:40 pm
A former Mid-Missouri state representative who dropped out of a state Senate race this week after a second cancer diagnosis wants to make sure people get regular screenings.
- CU Cancer Center Helps Lead National Trial to Evaluate Multicancer Blood Testson April 26, 2024 at 9:38 am
The Vanguard Study will evaluate whether the benefits of using blood tests to screen for multiple cancers outweigh the harms.
- Patients died after errors by blood cancer serviceon April 24, 2024 at 10:23 pm
Four people have died following errors in Birmingham blood cancer services, the BBC can reveal. The latest deaths, in 2023 at University Hospitals Birmingham (UHB), have prompted an inquiry by The ...
- Company developing early cancer-detection tests to cut 20% of workforceon April 24, 2024 at 7:35 am
Early cancer-detection test maker that raised $254 million earlier this year now says it will cut more than 100 jobs — about 20% of its workforce — as it restructures ...
- New Test Detects Cancer In Minutes Using Just 1 Drop of Dried Bloodon April 24, 2024 at 6:04 am
A test devised in Shanghai could make cancer detection quicker, easier, and practical for multiple areas of the body at once. Using just one drop of dried blood, the test looks for biomarkers that ...
- Balancing hope and reality: The promise and peril of blood-based colorectal cancer screeningon April 24, 2024 at 1:30 am
A simple blood test to detect colorectal cancer sounds amazing. But unlike colonoscopy, a blood test can't remove precancerous polyps.
- Arthritis linked to blood cancer mutationson April 23, 2024 at 10:20 am
A team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoid arthritis and gene mutations found in blood cancer.
- AI-powered tool detects cancer in minutes with one drop of bloodon April 23, 2024 at 6:52 am
Scientists in China have developed a test that detects three types of cancers with just one spot of dried blood.
- Researchers developing new colon cancer tests amid rising caseson April 23, 2024 at 3:01 am
With more than 200,000 cases of colon cancer diagnosed across the country every year, researchers are working on new ways to detect the disease better.
- Detecting cancer in minutes possible with just a drop of dried blood and new test, study hintson April 22, 2024 at 9:19 am
Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer.
via Bing News